Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin L Anderson

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Journal of the National Cancer Institute|January 5, 2002
Prostate cancer in bone: importance of context for inhibition of matrix metalloproteinasesMina J Bissell, Johanne Le Beyec, Robin L Anderson
Growth Factors (Chur, Switzerland)|July 6, 2019
Bone morphogenetic protein signaling in breast cancer progressionLap Hing Chi, Allan D Burrows, Robin L Anderson
Cancer Research|June 17, 2006
Transduction of tumor necrosis factor-related apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivoKeli Song, Nordine Benhaga, Robin L Anderson, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 16, 2011
Human neuroblastoma SH-SY5Y cells show increased resistance to hyperthermic stress after differentiation, associated with elevated levels of Hsp72Lesley Cheng, Danielle J Smith, Robin L Anderson, et al.
The Journal of Biological Chemistry|January 6, 2005
Hsp72 inhibits Fas-mediated apoptosis upstream of the mitochondria in type II cellsNicholas J Clemons, Katherine Buzzard, Rohan Steel, et al.
Plos One|September 15, 2011
Modulation of cellular Hsp72 levels in undifferentiated and neuron-like SH-SY5Y cells determines resistance to staurosporine-induced apoptosisLesley Cheng, Danielle J Smith, Robin L Anderson, et al.
Nature Reviews. Clinical Oncology|August 24, 2016
Does the mobilization of circulating tumour cells during cancer therapy cause metastasis?Olga A Martin, Robin L Anderson, Kailash Narayan, et al.
Frontiers in Oncology|August 25, 2015
Editorial: Cellular and Phenotypic Plasticity in CancerPetranel T Ferrao, Andreas Behren, Robin L Anderson, et al.
Frontiers in Oncology|May 29, 2019
Editorial: Cancer Plasticity and the Microenvironment: Implications for Immunity and Therapy ResponseAndreas Behren, Erik W Thompson, Robin L Anderson, et al.
Biochemical Society Transactions|January 11, 2019
Breast tumour organoids: promising models for the genomic and functional characterisation of breast cancerCharlotte Roelofs, Frédéric Hollande, Richard Redvers, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Journal of the National Cancer Institute|January 5, 2002
Prostate cancer in bone: importance of context for inhibition of matrix metalloproteinasesMina J Bissell, Johanne Le Beyec, Robin L Anderson
Growth Factors (Chur, Switzerland)|July 6, 2019
Bone morphogenetic protein signaling in breast cancer progressionLap Hing Chi, Allan D Burrows, Robin L Anderson
Cancer Research|June 17, 2006
Transduction of tumor necrosis factor-related apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivoKeli Song, Nordine Benhaga, Robin L Anderson, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 16, 2011
Human neuroblastoma SH-SY5Y cells show increased resistance to hyperthermic stress after differentiation, associated with elevated levels of Hsp72Lesley Cheng, Danielle J Smith, Robin L Anderson, et al.
The Journal of Biological Chemistry|January 6, 2005
Hsp72 inhibits Fas-mediated apoptosis upstream of the mitochondria in type II cellsNicholas J Clemons, Katherine Buzzard, Rohan Steel, et al.
Plos One|September 15, 2011
Modulation of cellular Hsp72 levels in undifferentiated and neuron-like SH-SY5Y cells determines resistance to staurosporine-induced apoptosisLesley Cheng, Danielle J Smith, Robin L Anderson, et al.
Nature Reviews. Clinical Oncology|August 24, 2016
Does the mobilization of circulating tumour cells during cancer therapy cause metastasis?Olga A Martin, Robin L Anderson, Kailash Narayan, et al.
Frontiers in Oncology|August 25, 2015
Editorial: Cellular and Phenotypic Plasticity in CancerPetranel T Ferrao, Andreas Behren, Robin L Anderson, et al.
Frontiers in Oncology|May 29, 2019
Editorial: Cancer Plasticity and the Microenvironment: Implications for Immunity and Therapy ResponseAndreas Behren, Erik W Thompson, Robin L Anderson, et al.
Biochemical Society Transactions|January 11, 2019
Breast tumour organoids: promising models for the genomic and functional characterisation of breast cancerCharlotte Roelofs, Frédéric Hollande, Richard Redvers, et al.
Pageof 10